PhinC is a Contract Research Organization (CRO) specialized in Quantitative Pharmacology Solutions to support biotechs in the development of drug candidates, new chemical and biological entities. We rely on the Model Informed Drug Development (MIDD) approach to make informed decisions supported by analyses and modeling. This strategy allows us to integrate quantitative modeling & simulations to optimize drug development, predict pharmacological responses, and identify the best dosing strategies.